CATX NYSE · Healthcare · FY 2025-12-31

Perspective Therapeutics, Inc.

0.00.81.62.43.1ABVfair 2.25buy —EPVnot valid for this companyEBVnot valid for this companyDBVnot valid for this companyprice 2.91 USD
ABV EPV EBV DBV fair value / share buy at or below (margin of safety applied) margin-of-safety band current price values in USD
Verdict
Avoid
Buy zone
Overvalued
Archetype
Distressed/Deficit
Confidence
●○○ Low · 1/4

Price
2.910 USD
Market cap
216.3M USD
P / B
1.04
P / E
EPS
-1.400
DPS / yield
(0.0%)
NAV / share
2.247
Graham number
Z'' score
-0.14
Piotroski F
1 / 9
Beneish M
ROIC vs WACC
-52.7% vs 15.8%

See the full orchestrator pipeline — solvency gate, lens cascade, reconciliation, archetype, decision, and confidence.

Subscribe to unlock this and every other tab for every company.

See the full ABV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EPV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full EBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.

See the full DBV lens breakdown — gates, steps, and verdict.

Subscribe to unlock this and every other tab for every company.